These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 5942126)

  • 1. [Experimental coronary-dilatator action of derivatives of phenyl-propyl-di-indolylpropylamine and phenyl-propyl-diphenylpropylamine].
    Mercier F; Gavend MR; Gavend M
    Therapie; 1966; 21(3):599-614. PubMed ID: 5942126
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacological studies of 3-(3,3-diphenylpropylamino)-propyl-3',4',5'-trimethoxybenzoate (PF-26), a new coronary vasodilator.
    Hatano N; Sohji Y; Kawashima K; Kaneko H
    Arzneimittelforschung; 1971 Nov; 21(11):1628-33. PubMed ID: 5172070
    [No Abstract]   [Full Text] [Related]  

  • 3. [Aspects of the action of odiphaline hydrochloride 3-phenyl-3-O-hydroxyphenyl-N-(phenylisopropyl) propylamine on the cardiovascular system].
    Avakian OM; Kaltrikian AA; Stepanian NO
    Zh Eksp Klin Med; 1979; 19(4):9-14. PubMed ID: 506583
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies with coronary-active drugs.
    Haas H
    Brux Med; 1970 Sep; 50(9):665-8. PubMed ID: 5510369
    [No Abstract]   [Full Text] [Related]  

  • 5. [Epontol and coronary circulation].
    Garcia Betancourt L
    Anaesthesist; 1970 Jan; 19(1):48-51. PubMed ID: 5440158
    [No Abstract]   [Full Text] [Related]  

  • 6. The cardiovascular pharmacology of lidoflazine.
    Schaper W; Jageneau A; Xhonneux R
    Brux Med; 1970 Sep; 50(9):635-8. PubMed ID: 5510364
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparative experimental studies on the coronary vasodialator action of N-(3-phenylisopropyl)-3,3-diphenylpropylamine].
    KOCHSIEK K; BRETSCHNEIDER HJ; SCHELER F
    Arzneimittelforschung; 1960 Aug; 10():576-83. PubMed ID: 13757378
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of hexobendine on cardiac metabolism and blood supply.
    Raberger G; Kraupp O
    Brux Med; 1970 Sep; 50(9):645-50. PubMed ID: 5510366
    [No Abstract]   [Full Text] [Related]  

  • 9. [On the necessity to resume and enlarge pharmacologic and clinical studies of a molecule during the advancement of its therapeutic utilization: pharmacology of trimetazidine].
    Vigne J
    Brux Med; 1970 Sep; 50(9):601-8. PubMed ID: 5510360
    [No Abstract]   [Full Text] [Related]  

  • 10. [N-(3-phenylisopropyl)-3,3-diphenylpropylamine, a new substance with a dilating action on the coronary vessels. Part 1: Action on the circulation].
    LINDNER E
    Arzneimittelforschung; 1960 Aug; 10():569-73. PubMed ID: 13762379
    [No Abstract]   [Full Text] [Related]  

  • 11. [N-(3-phenylisopropyl)-3,3-diphenylpropylamine, a new substance with a dilating action on the coronary vessels. Part 2: Further pharmacological effects].
    LINDNER E
    Arzneimittelforschung; 1960 Aug; 10():573-6. PubMed ID: 13762380
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiovascular effects of Sintamil & Imipramine.
    Kaul CL; Grewal RS
    Indian J Exp Biol; 1974 May; 12(3):243-6. PubMed ID: 4448481
    [No Abstract]   [Full Text] [Related]  

  • 13. DIPHENYLPROPYLAMINE DERIVATIVES. I. N-SUBSTITUTED 3,3-DIPHENYLPROPYLAMINES.
    HARSANYI K; KORBONITS D; KISS P
    J Med Chem; 1964 Sep; 7():623-5. PubMed ID: 14233172
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of anisodamine on cardiovascular activities in endotoxin-shocked dogs.
    Yao T; Xiao YF; Sun XY; Tong HH; Yuan M; Xu ZY; Dai ZY
    Chin Med J (Engl); 1984 Dec; 97(12):871-6. PubMed ID: 6443282
    [No Abstract]   [Full Text] [Related]  

  • 15. [A study of cardiovascular and antiarrhythmic effects of alizapride (author's transl)].
    Cheymol G; Mouillé P
    Sem Hop; 1982 Feb; 58(6):333-8. PubMed ID: 6280298
    [No Abstract]   [Full Text] [Related]  

  • 16. Proceedings: Effects of 3-(bis(3,3-diphenylpropyl)-amino)-propane-l-OL hydrochloride, PF-244, on cerebral hemodynamics--antagonism to vasoconstrictive agents.
    Kadokawa T; Fujitani B; Kuwashima J; Yoshida K; Shimizu M
    Jpn J Pharmacol; 1974; 24(0):s:67. PubMed ID: 4545968
    [No Abstract]   [Full Text] [Related]  

  • 17. [Action of oxyphedrin on the coronary circulation studied by dye dilution curves].
    Barbosa J; Lopes AS; Lopes JS; Veloso LF; Benchimol AB
    Arq Bras Cardiol; 1973 Apr; 26(2):161-5. PubMed ID: 4581415
    [No Abstract]   [Full Text] [Related]  

  • 18. Regional blood flow and cardiac responses to hydralazine.
    Spokas EG; Wang HH
    J Pharmacol Exp Ther; 1980 Feb; 212(2):294-303. PubMed ID: 7351643
    [No Abstract]   [Full Text] [Related]  

  • 19. [The effect of phenyl-2(1-phenyl propyl(3)amino)-propane hydrochloride on beta-adrenergic structures].
    Manolov P
    Eksp Med Morfol; 1971; 10(3):177-80. PubMed ID: 5155695
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiovascular effects of (2RS,3SR)- 2-aminomethyl-2,3,7,8-tetrahydro-2,3,5,8,8-pentamethyl-6H-furo- [2,3-e]indol-7-one hydrochloride (UK-1745), a novel cardiotonic agent with vasodilatory and antiarrhythmic properties.
    Uchida Y; Kawada M; Sawanobori K; Sonoki H; Inoue K; Mizuno K; Itou T; Tabunoki Y; Tsukamoto M; Ohashi Y; Kyotani Y; Shimizu N; Fujii M; Nakamura M
    Arzneimittelforschung; 1998 Mar; 48(3):219-31. PubMed ID: 9553677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.